Clinical Trial Update: Long-term Safety, Tolerability and Efficacy of Idebenone in Duchenne Muscular Dystrophy (DELPHI Extension) [Phase 2]

View source ↗

Summary

Long-term safety, tolerability, and efficacy data from the DELPHI extension of idebenone in Duchenne muscular dystrophy (Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Duchenne Muscular Dystrophy | Phase 2 | Status: COMPLETED